Skip to content
Search

Latest Stories

RPS president Sandra Gidley not to seek reelection

Sandra Gidley, first female president of the Royal Pharmaceutical Society (RPS), has announced that she will be stepping down from the role this June.

Gidley said she will not be contesting in the English Pharmacy Board elections this year.


Gidley served as the chair of the English Pharmacy Board from 2015-2019, before being elected as the RPS president in July 2019. Her term ends in June.

"I have always been a strong supporter of a maximum number of terms for an elected board member. I strongly believe that this is good governance and that it brings new thinking into the organisation," Gidley said, commenting on the reason of her decision.

"I cannot think of a better way of demonstrating my commitment to this than to stand aside myself, with the hope that new candidates will be successful in this election."

During her tenure as the top executive of the English Pharmacy Board, the RPS in England led on the creation of new roles for pharmacists in general practice, care homes, and urgent care.

Under her leadership, the RPS has also lobbied successfully for community pharmacists to gain access to patient care records and won an end to the automatic criminalisation of dispensing errors, among others.

Most recently as president, Gidley has overseen the RPS response to Covid-19 as well as initiatives to improve the inclusion, diversity and wellbeing of the profession.

Reflecting on her time as president, Gidley said: "I have had the double privilege of being both Board Chair of the RPS English Pharmacy Board and President. I have sought to serve the profession through many difficult times – none more so than the current Covid-19 crisis, which has asked a lot, in some cases far too much, of our profession.

"I leave with a sense of optimism about the future but I do not underestimate the work that remains to make sure all sectors of pharmacy get the recognition they deserve."

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less